Since the federal hemp ban was signed into law in November 2025, the industry has been searching for a legislative lifeline — a bill that could preserve the hemp consumable market without dismantling the regulatory framework that 2026 demands.
That bill exists. It's called the Cannabinoid Safety and Regulation Act (CSRA), introduced by U.S. Senators Ron Wyden and Jeff Merkley — and for B2B hemp operators, it's worth understanding in detail.
What the CSRA Proposes
The CSRA is an 84-page bill that would establish a federal regulatory framework for hemp-derived cannabinoid products rather than banning them outright.
The core provisions:
- Consumable hemp products permitted with up to 5mg of THC per serving and 50mg of THC per container for edibles, topicals, and inhalables
- Beverages allowed up to 10mg of THC per container
- Products subject to labeling requirements, age restrictions, and safety standards
- FDA given clearer authority to regulate cannabinoid products within defined parameters
How the CSRA Differs From the Current Law
The current law takes a binary approach: make most intoxicating products unlawful by November 12, 2026.
The CSRA takes a calibration approach: establish what is permitted, at what concentrations, with what safeguards.
| Current Law | CSRA | |
|---|---|---|
| Per-container limit | 0.4mg total THC | 50mg total THC |
| Difference | — | 125× more permissive |
For the majority of hemp brands currently operating, CSRA-compliant products would be far easier to produce than products compliant with the November 2026 threshold.
Why the CSRA Hasn't Gained Traction Yet
The CSRA faces structural headwinds in the current Congress:
- Introduced by Democratic senators, limiting bipartisan appeal in a Republican-controlled Senate
- The House Agriculture Committee passed the Farm Bill with the hemp ban intact
- Congress tends not to act urgently on issues with deadlines still months away
- The industry's strongest advocacy window is likely Q2–Q3 2026
Positioning for Both Outcomes
The strategic posture for B2B hemp manufacturers right now is not to bet on the CSRA passing — it's to prepare for both scenarios simultaneously:
- Recalculate formulations for November 2026 compliance (0.4mg/container)
- Understand your CSRA exposure — know which SKUs survive under 50mg/container
- Document obsessively — both legal frameworks reward clean, auditable supply chains
- Monitor legislative calendar through Q2–Q3 2026
🌿 LOW GRAVITY HEMP PERSPECTIVE
At Low Gravity Hemp, we don't take regulatory positions — we track them so our manufacturing partners don't have to. Whether the CSRA passes or the November standard holds, documentation discipline and ingredient consistency are what determine which operators survive the transition. Our ingredients are built for audit-readiness under any scenario.
Final Thoughts
The CSRA is the most credible legislative alternative to the November 2026 ban. Whether it passes or not, understanding it matters — because it defines what a regulated hemp future looks like, and gives manufacturers a preview of the compliance demands they'll face either way.
👉 Visit the Low Gravity Hemp News Hub for ongoing updates on hemp legislation and compliance strategy.
